4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-009096
Chief Executive Officer sold 30,000 shares at an average $17.65 ($529,491)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Violin Jonathan Chief Executive Officer | 2022-03-01 | Sale | −18,894 | $17.82 | $336,691 | 582,011 | D |
| Violin Jonathan Chief Executive Officer | 2022-03-02 | Sale | −11,106 | $17.36 | $192,800 | 570,905 | D |
| Open-market sales · 30,000 sh · avg $17.65 · $529,491 | |||||||
Loading xslF345X03/doc4.xml…